Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A medicine and athlete's foot technology are applied in the field of medicines for the treatment of athlete's foot, can solve the problems of high cost, can not cure athlete's foot, no effective western medicine for athlete's foot, etc., and achieve the effects of low cost, obvious curative effect and obvious therapeutic effect.
Inactive Publication Date: 2014-08-06
HUZHOU KONCH PHARMA
View PDF5 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There are many medicines for treating athlete’s foot on the market, some of which cannot achieve the purpose of radically curing athlete’s foot, and there is sti...
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0010] A medicine for treating athlete's foot, comprising the following components in parts by weight: 30 parts of Phellodendron Phellodendri, 30 parts of salicylic acid, 40 parts of white tinea cortex, 30 parts of tangerine peel, 45 parts of sophora flavescens, 12 parts of Chinese gallnut, 40 parts of yellow lotus, 40 parts of bezoar, 30 parts of borneol, 10 parts of Mituseng, 10 parts of iron amaranth, 30 parts of alum, 20 parts of dried ginger, 30 parts of mylabris, 60 parts of sage rattan, 50 parts of Chuanxiong, 20 parts of Panax notoginseng, and 20 parts of black plum.
Embodiment 2
[0012] A medicine for treating athlete's foot, comprising the following components in parts by weight: 50 parts of Phellodendron Phellodendri, 20 parts of salicylic acid, 20 parts of white tinea cortex, 10 parts of tangerine peel, 25 parts of Sophora flavescens, 4 parts of Chinese Gallnut, 20 parts of Coptis chinensis, 30 parts of bezoar, 20 parts of borneol, 5 parts of Mituseng, 6 parts of amaranth, 15 parts of alum, 10 parts of dried ginger, 10 parts of mylabris, 40 parts of Sagevine, 30 parts of Chuanxiong, 10 parts of Panax notoginseng, and 10 parts of black plum.
Embodiment 3
[0014] A medicine for treating athlete's foot, comprising the following components in parts by weight: 35 parts of Phellodendron Phellodendri, 28 parts of salicylic acid, 35 parts of white tinea cortex, 25 parts of dried tangerine peel, 40 parts of Sophora flavescens, 10 parts of Galla chinensis, 35 parts of Coptis chinensis, 37 parts of bezoar, 28 parts of borneol, 9 parts of Mituseng, 9 parts of amaranth, 25 parts of alum, 17 parts of dried ginger, 25 parts of mylabris, 55 parts of Sagevine, 45 parts of Chuanxiong, 16 parts of Panax notoginseng, and 17 parts of black plum.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine for treating tinea pedis. The medicine is characterized by being prepared from the following components in parts by weight: 30-50 parts of golden cypress, 20-30 parts of salicylic acid, 20-40 parts of cotex dictamni, 10-30 parts of pericarpium citri reticulatae, 25-45 parts of radix sophorae flavescentis, 4-12 parts of gallnuts, 20-40 parts of goldthread roots, 30-40 parts of calculus bovis, 20-30 parts of borneol, 5-10 parts of lithargite, 6-10 parts of acalypha australis, 15-30 parts of alumen, 10-20 parts of rhizoma zingiberis, 10-30 parts of Chinese blister beetles, 40-60 parts of mucuna macrocarpa wallich, 30-50 parts of ligusticum wallichii, 10-20 parts of pseudo-ginseng and 10-20 parts of smoked plums. The medicine for treating tinea pedis provided by the invention can treat tinea pedis with two courses of treatment commonly and is remarkable in curative effect and low in cost. 60% of the patients with tinea pedis are cured by the medicine within one course of treatment and 35% of the patients are cured within two courses of treatment. The medicine is remarkable in curative effect and free from adverse reactions.
Description
technical field [0001] The invention relates to a medicine for treating athlete's foot. Background technique [0002] Athlete's foot is a very common fungal infectious skin disease, and athlete's foot is "the wild inflammation is endlessly burned, and the spring breeze blows and regenerates", which shows that athlete's foot is refractory and easy to relapse. At present, 70-80% of adults have athlete's foot, but the severity is different. It is often aggravated in summer and alleviated in winter, and some people do not heal all the year round. The medicine for the treatment of athlete's foot is a lot on the market, and some can not reach the purpose of radically curing athlete's foot, and the treatment of athlete's foot still does not have specific western medicine, and cost is also higher, and pin also has certain injury, and effect is not good. Contents of the invention [0003] Aiming at the problems existing in the prior art, the purpose of the present invention is to ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more